These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
122 related items for PubMed ID: 2417361
1. Monoclonal antibody to glycoprotein Ib inhibits both thrombin- and ristocetin-induced platelet aggregations. Yamamoto N, Kitagawa H, Tanoue K, Yamazaki H. Thromb Res; 1985 Sep 15; 39(6):751-9. PubMed ID: 2417361 [Abstract] [Full Text] [Related]
2. Localization of von Willebrand factor and thrombin-interactive domains on human platelet glycoprotein Ib. Katagiri Y, Hayashi Y, Yamamoto K, Tanoue K, Kosaki G, Yamazaki H. Thromb Haemost; 1990 Feb 19; 63(1):122-6. PubMed ID: 2339348 [Abstract] [Full Text] [Related]
3. Characterization of an antiglycoprotein Ib monoclonal antibody that specifically inhibits platelet-thrombin interaction. Mazurov AV, Vinogradov DV, Vlasik TN, Repin VS, Booth WJ, Berndt MC. Thromb Res; 1991 Jun 15; 62(6):673-84. PubMed ID: 1718052 [Abstract] [Full Text] [Related]
4. A murine antiglycoprotein Ib complex monoclonal antibody, SZ 2, inhibits platelet aggregation induced by both ristocetin and collagen. Ruan CG, Du XP, Xi XD, Castaldi PA, Berndt MC. Blood; 1987 Feb 15; 69(2):570-7. PubMed ID: 3801672 [Abstract] [Full Text] [Related]
5. Monoclonal antibodies to platelet glycoproteins Ib and IIb/IIIa inhibit adhesion of platelets to purified solid-phase von Willebrand factor. Danton MC, Zaleski A, Nichols WL, Olson JD. J Lab Clin Med; 1994 Aug 15; 124(2):274-82. PubMed ID: 8051492 [Abstract] [Full Text] [Related]
6. Thrombin decreases von Willebrand factor binding to platelet glycoprotein Ib. George JN, Torres MM. Blood; 1988 May 15; 71(5):1253-9. PubMed ID: 3258766 [Abstract] [Full Text] [Related]
7. Identification of receptors for fibrinogen and von Willebrand factor mediating aggregation in guinea pig platelets. Kupinski JM, Miller JL. Thromb Res; 1986 Aug 01; 43(3):335-44. PubMed ID: 3016944 [Abstract] [Full Text] [Related]
8. Monoclonal antibody to human platelet glycoprotein I. II. Effects on human platelet function. Ruan C, Tobelem G, McMichael AJ, Drouet L, Legrand Y, Degos L, Kieffer N, Lee H, Caen JP. Br J Haematol; 1981 Dec 01; 49(4):511-9. PubMed ID: 6797459 [Abstract] [Full Text] [Related]
9. Studies investigating platelet aggregation and release initiated by sera from patients with thrombotic thrombocytopenic purpura. Kelton JG, Moore JC, Murphy WG. Blood; 1987 Mar 01; 69(3):924-8. PubMed ID: 3493046 [Abstract] [Full Text] [Related]
10. Interaction of purified type IIB von Willebrand factor with the platelet membrane glycoprotein Ib induces fibrinogen binding to the glycoprotein IIb/IIIa complex and initiates aggregation. De Marco L, Girolami A, Zimmerman TS, Ruggeri ZM. Proc Natl Acad Sci U S A; 1985 Nov 01; 82(21):7424-8. PubMed ID: 2932740 [Abstract] [Full Text] [Related]
11. Platelets have more than one binding site for von Willebrand factor. Ruggeri ZM, De Marco L, Gatti L, Bader R, Montgomery RR. J Clin Invest; 1983 Jul 01; 72(1):1-12. PubMed ID: 6223940 [Abstract] [Full Text] [Related]
12. Monoclonal antibodies against human platelet membrane glycoproteins IIb-IIIa. II. Different effects on platelet function. Heinrich D, Scharf T, Santoso S, Clemetson KJ, Mueller-Eckhardt C. Thromb Res; 1985 Jun 01; 38(5):547-59. PubMed ID: 2409615 [Abstract] [Full Text] [Related]
14. Ristocetin and botrocetin involve two distinct domains of von Willebrand factor for binding to platelet membrane glycoprotein Ib. Girma JP, Takahashi Y, Yoshioka A, Diaz J, Meyer D. Thromb Haemost; 1990 Oct 22; 64(2):326-32. PubMed ID: 1702906 [Abstract] [Full Text] [Related]
15. A monoclonal antibody recognizes a von Willebrand factor domain within the amino-terminal portion of the subunit that modulates the function of the glycoprotein IB- and IIB/IIIA-binding domains. Tornai I, Arnout J, Deckmyn H, Peerlinck K, Vermylen J. J Clin Invest; 1993 Jan 22; 91(1):273-82. PubMed ID: 8423224 [Abstract] [Full Text] [Related]
16. Role of platelet membrane glycoproteins Ib/IX and IIb/IIIa, and of platelet alpha-granule proteins in platelet aggregation induced by human osteosarcoma cells. Clezardin P, Drouin J, Morel-Kopp MC, Hanss M, Kehrel B, Serre CM, Kaplan C, Delmas PD. Cancer Res; 1993 Oct 01; 53(19):4695-700. PubMed ID: 7691402 [Abstract] [Full Text] [Related]
17. Platelet microparticle formation and thrombin generation under high shear are effectively suppressed by a monoclonal antibody against GPIba. Pontiggia L, Steiner B, Ulrichts H, Deckmyn H, Forestier M, Beer JH. Thromb Haemost; 2006 Dec 01; 96(6):774-80. PubMed ID: 17139372 [Abstract] [Full Text] [Related]
18. Studies with a murine monoclonal antibody that abolishes ristocetin-induced binding of von Willebrand factor to platelets: additional evidence in support of GPIb as a platelet receptor for von Willebrand factor. Coller BS, Peerschke EI, Scudder LE, Sullivan CA. Blood; 1983 Jan 01; 61(1):99-110. PubMed ID: 6336654 [Abstract] [Full Text] [Related]
19. Protein tyrosine phosphorylation in human platelets induced by interaction between glycoprotein Ib and von Willebrand factor. Ozaki Y, Satoh K, Yatomi Y, Miura S, Fujimura Y, Kume S. Biochim Biophys Acta; 1995 Apr 13; 1243(3):482-8. PubMed ID: 7537105 [Abstract] [Full Text] [Related]